-+ 0.00%
-+ 0.00%
-+ 0.00%

CYTOKINETICS: PLANS TO SUBMIT SUPPLEMENTAL NDA TO U.S. FDA FOR AFICAMTEN FOR TREATMENT OF ADULT PATIENTS WITH SYMPTOMATIC NHCM IN Q4

Reuters·08/28/2026 09:45:00

Please log in to view news